Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Clinical trial NCT00168038 · COMPLETED

Trial details

NCT number: NCT00168038
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2004-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.